Expert: Linvoseltamab’s Simplified Dosing Expands Access, Enhances Tolerability in Multiple Myeloma
Sundar Jagannath, MD, MBBS, discusses how linvoseltamab’s streamlined step-up dosing and REMS program support broader use in community settings and…
Astegolimab Reduces COPD Exacerbations in Clinical Trials
Astegolimab shows promise in reducing chronic obstructive pulmonary disease (COPD) exacerbations, offering hope for improved management of this debilitating lung…
Hospitalized Older Adults With COVID-19 Face Accelerated Cognitive Decline
Hospitalized older adults infected with SARS-CoV-2 had faster declines in executive function and memory compared with both uninfected and nonhospitalized…
Pharmacists’ Guide to Selection and Use of At-Home Blood Pressure Monitors
The American Heart Association recommends an automatic, cuff-style upper arm monitor.
Leveraging the EMR: How Pharmacists Improve Medication Safety in Practice
Pharmacist share actionable insights for EMR utilization and facilitation of medication safety practices.
How Pharmacist-Led Initiatives Reduce Adverse Drug Events
Pharmacists share their institution’s individual, unique approaches to medication safety.
Gedatolisib Doublet, Triplet Regimens Improve PFS in Patients With PIK3CA Wild-Type HR+/HER2– Breast Cancer
Emerging trial results reveal gedatolisib significantly enhances progression-free survival (PFS) in advanced HR+/HER2- breast cancer.
Clinical Perspective: Lenacapavir Demonstrates 100% Efficacy in PURPOSE Trials for Twice-Yearly HIV PrEP
Namrata Shah, MD, highlights lenacapavir’s ease of use, long-acting protection, and the vital role pharmacists play in expanding equitable HIV…
A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
Experts discuss groundbreaking Hot Line trials at the European Society of Cardiology Congress 2025, offering insights into the latest cardiovascular…
Study Evaluates Financial Implications, Socioeconomic Profile of Patients With Diabetes
A new study reveals that individuals with type 2 diabetes (T2D) face significant financial hardships, impacting their health and medication…